Johnson & Johnson MedTech | Heart Recovery for HCPs

Johnson & Johnson MedTech | Heart Recovery is a global leader in cardiovascular medical technologies, focusing on heart recovery solutions to enhance patient outcomes in conditions like heart failure and stroke. As a business unit of Johnson & Johnson MedTech, it integrates the innovative Impella® heart pump technology, acquired from Abiomed in 2022, into its offerings. The company provides a range of advanced products, including the Impella heart pumps, which are designed to temporarily take over the heart's pumping function, allowing it to rest and recover. Their portfolio also features mapping and navigation systems, miniaturized technologies, and tools for treating cardiac arrhythmias and heart failure. Additionally, they offer training platforms and software services to support healthcare professionals in utilizing these technologies effectively. Johnson & Johnson MedTech | Heart Recovery is dedicated to making heart recovery the global standard of care, emphasizing a patient-first approach. Their mission includes promoting awareness of heart recovery and expanding access to life-saving treatments for healthcare professionals worldwide.

• Employees 24